Opioids Market Size is projected to expand at a significant pace from 2022 to 2028, driven by the rising cases of orthopedic diseases, cancer, HIV, and other pain inducing diseases. As per reliable estimates, chronic pain affects nearly 10% of the global population, with estimates of the same closer to 20-25% in some regions and countries. An additional 1 in 10 people suffer from chronic pain every year globally.
In addition, the growing geriatric population and surge in disposable incomes would as well propel the growth of market over the span of 2022-2028.
Opioids are naturally occurring, semi-synthetic, or synthetic compounds that interact with opioid receptors in the nervous system and alleviate the pain of treatments and injuries. Increased recommendation from healthcare professionals, patients, and other options owing to their easy availability and reasonable cost has complemented the growing drug demand worldwide.
However, the addictive nature of opioids has led to its drug misuse while also posing various side effects including drowsiness, nausea, constipation, euphoria, confusion, and more. According to WHO estimates, about 0.5 million deaths worldwide are a result of drug use. More than 70% of these fatalities are associated with opioids. These factors are expected to challenge the opioids market growth.
In terms of the drug class, semi-synthetic opioids are expected to gain significant momentum in the coming years, owing to the growing presence and demand for these pain-reducing drugs. Semi-synthetic opioids are synthesized in labs from natural opiates. These drugs include oxycodone, hydromorphone, and hydrocodone. Both Oxycodone and hydrocodone are generally combined with acetaminophen and prescribed in pill form for various cancer-related pain or post-surgical pain. According to credible studies, hydrocodone has nearly 123.3 million prescriptions in the previous decade.
Based on the release type, long-acting opioids, also known as extended-release opioids, would account for considerable growth in the overall opioids market through 2028. These medicines are commonly used to relieve moderate to severe long-term pain. The therapeutic benefits associated with these drugs include consistent and sustained analgesia and decreased dosing frequency. Besides, the pharmacokinetic profiles of ER opioids offer the advantage of reduced frequency of sleep disturbances, steady plasma concentrations, and decreased end of dose failure. Some of the prominent long-acting opioids are methadone, fentanyl patch, oxycodone controlled-release, and methadone.
The demand for opioids is gradually surging amongst patients with complaints of acute cancer pain. It has been reported that approximately 55% of cancer patients and 40% of survivors experience chronic cancer-related pain. Moreover, it was revealed that 43% of patients with cancer and 10% of cancer survivors use opioids to manage chronic cancer pain, with claims of 2/3rd patients surviving beyond 5 years. Such factors are expected to boost the growth of cancer pain segment across the global opioids market through the forthcoming years.
Geographically, Asia Pacific opioids market would foresee substantial gains over the forthcoming years. This can be credited to the growing number of cancer cases in various developing economies like China, India, Japan, South Korea, and others. Asia accounts for nearly half the global burden of cancer. Furthermore, expanding geriatric population and incidences of chronic pain would boost the regional market demand.
The global opioids industry is highly consolidated and boasts the presence of Teva Pharmaceuticals Industries Ltd., Purdue Pharma L.P, Mallinckrodt Pharmaceuticals, Amneal Pharmaceuticals, Inc., and Endo International, amongst others. These companies are taking up various strategic measures including mergers and acquisitions, partnerships, and product launches, to gain a competitive edge in the overall marketplace.
COVID-19 crisis and its impact on opioids market share
The coronavirus pandemic outbreak during 2020 has had a positive impact on the global market as it acts as a pain-reducing agent. Also, a large number of the population started stocking opioids medicine due to government restrictions and lockdown norms. During the pandemic, the market expanded considerably because of rising chronic diseases, increased health concerns, and growing demand for opioids.
The opioids market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2028 for the following segments:
Market, By Class
Market, By Release Type
Market, By Product
Market, By Application
Market, By Brand
Market, By Route of Administration
Market, By Mechanism of Action
The above information is provided for the following regions and countries: